Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2016 0 · FY2017 0 · FY2018 0
Operates in Healthcare Services — General medicine - private practice. Per the activity note to the FY2024 annual report, the company provides comprehensive medical services including laboratory, dermatology, endocrinology, neurology, and oncology services. Founded in 2011. Offers full-service ambulatory laboratory and medical specialist consultations.
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 1,242 | 731 | 61 | 0 | 0 | 0 | 0 | 0 | -77.9% |
| Net Cash used in Investing Activities | 0 | 1,037 | 56 | 0 | 0 | 0 | 0 | 0 | -94.6% |
| Free Cash Flow (OCF − Capex proxy) | 1,242 | 306 | 5 | 0 | 0 | 0 | 0 | 0 | nmf |
| Net Cash from Financing Activities | 0 | 521 | 131 | 0 | 0 | 0 | 0 | 0 | -74.9% |
| Net Change in Cash (before FX) | 1,242 | 202 | 136 | 0 | 0 | 0 | 0 | 0 | -66.9% |
| Effect of FX on Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | +43.9% |
| Net Change in Cash (incl. FX) | 1,242 | 202 | 136 | 0 | 0 | 0 | 0 | 0 | -66.9% |
| Cash at Beginning of Year | 0 | 303 | 100 | 236 | 315 | 247 | 0 | 0 | -4.9% |
| Cash at End of Year | 0 | 100 | 236 | 236 | 315 | 247 | 0 | 0 | +25.3% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →